SLT is a cost-effective, first-line glaucoma approach Dr. Nate Radcliffe shares how Lumenis SLT is a cost-effective first-line approach for patients with glaucoma in this video from ASCRS San Diego. Read Full ArticleNathan M. Radcliffe, MD Explore Other Resources Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubOD Brings In Technology To Help Patients Get Off The Hamster Wheel Of Dry Eye TreatmentsDry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubTeaching Peers About Dry Eye Disease Boosts Patients’ Access to CareDry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubHow a Boutique Dry Eye Clinic in an Unexpected Spot Drew $45,000 in the First 9 Months. PB-00038930 Rev A
Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubOD Brings In Technology To Help Patients Get Off The Hamster Wheel Of Dry Eye Treatments
Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubTeaching Peers About Dry Eye Disease Boosts Patients’ Access to Care
Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubHow a Boutique Dry Eye Clinic in an Unexpected Spot Drew $45,000 in the First 9 Months.